Finally, the writing group would like to thank Lori Hinrichs for her superb assistance with the preparation of this manuscript. Wilson et al Prevention of Infective Endocarditis 1749 Disclosures Writing Group Disclosures Writing Group Member Employment Research Grant Other Research Support Speakers Bureau/ Honoraria Ownership Interest Consultant/ Advisory Board Other Walter Wilson Mayo Clinic None None None None None None Larry M. Baddour Mayo Clinic None None None None None None Robert S. Baltimore Yale University School of Medicine None None None None None None Ann Bolger University of California, San Francisco None None None None None None Robert O. Bonow Northwestern University Feinberg School of Medicine None None None None None None Jane C. Burns University of California, San Diego None None None None None None Christopher H. Cabell Duke University National Institutes of Health None None None Gloucester*; Shire*; Cubist*; Carbomedics*; GlaxoSmithKline*; Acusphere*; Endo*; Eli Lilly*; Watson*; Johnson & Johnson* None David T. Durack Becton Dickinson & Co (manufactures medical devices and diagnostics) None None None None Joint Commission Resources Board None Patricia Ferrieri University of Minnesota Medical School None None None None None None Timothy Gardner Christiana Care Health System None None None None None None Michael Gerber Cincinnati Children s Hospital Medical Center None None None None None None Michael Gewitz Maria Fareri Children s Hospital of Westchester, New York Medical College None None None None None None David Goff Wake Forest University School of Medicine None None None None Spriggs & Hollingsworth Law Firm; Scientific Evidence Consulting Firm; GlaxoSmithKline* None Matthew Levison Drexel University College of Medicine None None None None Merck* None Peter B. Lockhart Carolinas Medical Center None None None None None None Jane W. Newburger Boston Children s Heart Foundation None None None None None None Thomas Pallasch University of Southern California None None None None Consultation and expert witness testimony on records of patients with endocarditis None Anne H. Rowley Children s Memorial Hospital, Chicago None None None None None None Stanford T. Shulman Children s Memorial Hospital, Chicago None None None None None None Brian L. Strom University of Pennsylvania School of Medicine Pfizer* Merck*; Novartis*; Wyeth*; Pfizer* None None Abbott*; GlaxoSmithKline*; Eli Lilly*; Pfizer*; Sanofi Pasteur*; Johnson & Johnson*; Schering AG*; Tap Pharma*; Wyeth* None Masato Takahashi University of Southern California Bristol-Myers Squibb Medical Imaging* None None None None None Lloyd Y. Tani University of Utah School of Medicine None None None None None None Kathryn A. Taubert American Heart Association None None None None None None This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. 